Amendment: SEC Form 144/A filed by Alzamend Neuro Inc.
$ALZN
Biotechnology: Pharmaceutical Preparations
Health Care
| Form 144 Filer Information |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 | |
FORM 144/A |
144/A: Filer Information
| Filer CIK | 0000896493 |
| Filer CCC | XXXXXXXX |
| Previous Accession Number Of The Filing | 0001214659-25-007333 |
| Is this a LIVE or TEST Filing? |  LIVE
 TEST
|
Submission Contact Information | |
| Name | |
| Phone | |
| E-Mail Address |
144/A: Issuer Information
| Name of Issuer | Alzamend Neuro, Inc. |
| SEC File Number | 001-40483 |
| Address of Issuer | 3480 Peachtree Road NE Second Floor, Suite 103 Atlanta GEORGIA 30326 |
| Phone | 844-722-6333 |
| Name of Person for Whose Account the Securities are To Be Sold | Hyperscale Data, Inc. |
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account
the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given
as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales
for the account of the person filing this notice.
| |
| Relationship to Issuer | 10% stockholder |
144/A: Securities Information
| Title of the Class of Securities To Be Sold | Name and Address of the Broker | Number of Shares or Other Units To Be Sold | Aggregate Market Value | Number of Shares or Other Units Outstanding | Approximate Date of Sale | Name the Securities Exchange |
|---|---|---|---|---|---|---|
| Common Stock | ETRADE Financial Corporation 3 Edison Drive Alpharetta � GA � 30005 | 939281 | 3005699.20 | 2896432 | 07/14/2025 | NASDAQ |
Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment
of all or any part of the purchase price or other consideration therefor:
144/A: Securities To Be Sold
| Title of the Class | Date you Acquired | Nature of Acquisition Transaction | Name of Person from Whom Acquired | Is this a Gift? | Date Donor Acquired | Amount of Securities Acquired | Date of Payment | Nature of Payment * |
|---|---|---|---|---|---|---|---|---|
| Common | 03/09/2021 | Private purchase | Shares were purchased directly from Issuer |  | 847 | 03/09/2021 | Cash | |
| Common | 05/17/2019 | Private purchase | Shares were purchased directly from Issuer | | 189 | 10/24/2019 | Cash | |
| Common | 01/30/2020 | Private purchase | Shares were purchased directly from Issuer | | 87 | 12/11/2020 | Cash | |
| Common | 05/10/2021 | Private purchase | Shares were purchased directly from Issuer | | 46 | 05/10/2021 | Cash | |
| Common | 06/15/2021 | Public purchase in IPO | Shares were purchased from underwriter in IPO | | 1481 | 06/15/2021 | Cash | |
| Common | 06/15/2021 | Open market purchases | Shares were purchased in open market transactions | | 81 | 06/30/2021 | Cash | |
| Common | 07/01/2021 | Open market purchases | Shares were purchased in open market transactions | | 59 | 07/30/2021 | Cash | |
| Common | 07/30/2021 | Private purchase | Shares were purchased directly from Issuer | | 987 | 07/30/2021 | Cash | |
| Common | 08/02/2021 | Open market purchases | Shares were purchased in open market transactions | | 26 | 08/27/2021 | Cash | |
| Common | 09/14/2021 | Open market purchases | Shares were purchased in open market transactions | | 3 | 09/14/2021 | Cash | |
| Common | 11/08/2021 | Open market purchases | Shares were purchased in open market transactions | | 125 | 11/30/2021 | Cash | |
| Common | 12/01/2021 | Open market purchases | Shares were purchased in open market transactions | | 47 | 12/31/2021 | Cash | |
| Common | 01/05/2022 | Open market purchases | Shares were purchased in open market transactions | | 16 | 01/27/2022 | Cash | |
| Common | 02/24/2022 | Open market purchases | Shares were purchased in open market transactions | | 16 | 02/24/2022 | Cash | |
| Common | 04/26/2022 | Private purchase | Shares were purchased directly from Issuer | | 1975 | 04/26/2022 | Cash | |
| Common | 05/06/2022 | Open market purchases | Shares were purchased in open market transactions | | 110 | 05/17/2022 | Cash | |
| Common | 05/21/2022 | Exercise of put option | Shares were purchased upon exercise of put option written by holder | | 3 | 05/21/2022 | Cash | |
| Common | 05/24/2022 | Open market purchases | Shares were purchased in open market transactions | | 28 | 05/27/2022 | Cash | |
| Common | 06/02/2022 | Open market purchases | Shares were purchased in open market transactions | | 43 | 06/29/2022 | Cash | |
| Common | 07/18/2022 | Open market purchases | Shares were purchased in open market transactions | | 13 | 07/27/2022 | Cash | |
| Common | 08/03/2022 | Open market purchases | Shares were purchased in open market transactions | | 60 | 08/26/2022 | Cash | |
| Common | 09/23/2022 | Open market purchases | Shares were purchased in open market transactions | | 57 | 09/29/2022 | Cash | |
| Common | 10/06/2022 | Open market purchases | Shares were purchased in open market transactions | | 7 | 10/31/2022 | Cash | |
| Common | 11/11/2022 | Shares issued for services rendered | Shares were acquired directly from Issuer | | 692 | 11/11/2022 | Cash | |
| Common | 12/19/2022 | Open market purchases | Shares were purchased in open market transactions | | 8 | 12/28/2022 | Cash | |
| Common | 03/16/2023 | Open market purchases | Shares were purchased in open market transactions | | 7 | 03/17/2023 | Cash | |
| Common | 12/28/2023 | Liquidation-in-kind | Shares were received from a hedge fund that liquidated in-kind to its investors | | 289 | 12/28/2023 | Cash | |
| Common | 01/05/2024 | Open market purchases | Shares were purchased in open market transactions | | 35 | 01/05/2024 | Cash | |
| Common | 01/31/2024 | Series B convertible preferred stock purchased | Shares to be received directly from Issuer when holder elects to convert | | 905172 | 01/31/2024 | Cash paid for Series B preferred stock | |
| Common | 03/28/2024 | Open market purchases | Shares were purchased in open market transactions | | 55 | 03/28/2024 | Cash | |
| Common | 04/01/2024 | Open market purchases | Shares were purchased in open market transactions | | 14 | 04/19/2024 | Cash | |
| Common | 07/31/2024 | Open market purchases | Shares were purchased in open market transactions | | 2 | 07/31/2024 | Cash | |
| Common | 08/06/2024 | Open market purchases | Shares were purchased in open market transactions | | 8 | 08/06/2024 | Cash | |
| Common | 03/12/2025 | Open market purchases | Shares were purchased in open market transactions | | 11 | 03/12/2025 | Cash | |
| Common | 03/18/2025 | Open market purchases | Shares were purchased in open market transactions | | 878 | 03/21/2025 | Cash | |
| Common | 03/09/2021 | Common stock purchase warrants | Shares to be received directly from Issuer when holder elects to exercise | | 25804 | 04/29/2024 | Cash to be paid upon exercise |
* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note
thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made
in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
144/A: Securities Sold During The Past 3 Months
| Name and Address of Seller | Title of Securities Sold | Date of Sale | Amount of Securities Sold | Gross Proceeds |
|---|---|---|---|---|
| Ault Lending, LLC c/o Hyperscale Data, Inc. 11411 Southern Highlands Prkwy, Ste 190 Las Vegas � NV � 89141 | Common Stock | 05/12/2025 | 1213 | 6138.00 |
144/A: Remarks and Signature
| Remarks | This filing amends the Form 144 filed on 05/09/25 to increase the number of shares that may be sold pursuant to Rule 144.Due to size limitations, some purchases have been aggregated. This shows where dates of payment and acquisition are different. In those situations, the purchase date represents the first date of shares in the group with the payment date being the last date of shares. All purchases, with dates and exact amounts, were previously disclosed on Forms 3/4 filings. The reporting person undertakes to provide, upon request by the SEC staff or a security holder of the issuer, full information regarding the number of shares purchased on each date for any aggregated disclosures. Shares to be sold upon conversion of series B convertible preferred and warrants are not currently owned as no conversions or exercises have yet occurred. Any conversion or exercise will be reported on a Form 4. The shares are owned by Ault Lending, LLC, a wholly owned subsidiary of Hyperscale Data, Inc. |
| Date of Notice | 07/11/2025 |
ATTENTION: | |
| The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. | |
| Signature | /s/ Milton C. Ault, III, Executive Chairman |
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001) | |